News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
South Korean multinational, Lotte Corporation, is to acquire Bristol Myers Squibb's manufacturing facility in East Syracuse, New York. The deal is reportedly worth US$160m.
AbbVie and Cugene Inc are teaming up on the development of therapies targeted at the potential treatment of autoimmune and inflammatory diseases.
RQ Biotechnology is launching as a new UK-based biotech: following the completion of a successful licensing deal with AstraZeneca for early-stage monoclonal antibodies targeted against SARS-CoV-2.
BeiGene is opening a new regional office in Basel, Switzerland: with the location serving as the hub for the company’s operations in the region.